{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:29:42Z","timestamp":1782386982396,"version":"3.54.5"},"reference-count":51,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-02179"],"award-info":[{"award-number":["2020-02179"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["NNF19OC0057339"],"award-info":[{"award-number":["NNF19OC0057339"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["2020-02179"],"award-info":[{"award-number":["2020-02179"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF19OC0057339"],"award-info":[{"award-number":["NNF19OC0057339"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Apolipoprotein A-I (ApoA-I) amyloidosis is a rare protein misfolding disease where fibrils of the N-terminal domain of the protein accumulate in several organs, leading to their failure. Although ApoA-I amyloidosis is systemic, the different amyloidogenic variants show a preferential tissue accumulation that appears to correlate with the location of the mutation in the protein sequence and with the local extracellular microenvironment. However, the factors leading to cell\/tissues damage, as well as the mechanisms behind the observed organ specificity are mostly unknown. Therefore, we investigated the impact of ApoA-I variants on cell physiology and the mechanisms driving the observed tissue specificity. We focused on four ApoA-I amyloidogenic variants and analyzed their cytotoxicity as well as their ability to alter redox homeostasis in cell lines from different tissues (liver, kidney, heart, skin). Moreover, variant-specific interactions with extracellular matrix (ECM) components were measured by synchrotron radiation circular dichroism and enzyme-linked immunosorbent assay. Data indicated that ApoA-I variants exerted a cytotoxic effect in a time and cell-type-specific manner that seems to be due to protein accumulation in lysosomes. Interestingly, the ApoA-I variants exhibited specific preferential binding to the ECM components, reflecting their tissue accumulation pattern in vivo. While the binding did not to appear to affect protein conformations in solution, extended incubation of the amyloidogenic variants in the presence of different ECM components resulted in different aggregation propensity and aggregation patterns.<\/jats:p>","DOI":"10.3390\/ijms24010318","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:40:39Z","timestamp":1672116039000},"page":"318","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-9413","authenticated-orcid":false,"given":"Rita","family":"Del Giudice","sequence":"first","affiliation":[{"name":"Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Lindvall","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktawia","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-0576","authenticated-orcid":false,"given":"Daria Maria","family":"Monti","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Napoli Federico II, Complesso Universitario Monte Sant\u2019Angelo, 80126 Napoli, Italy"},{"name":"Istituto Nazionale di Biostrutture e Biosistemi (INBB), 00136 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-2666","authenticated-orcid":false,"given":"Jens O.","family":"Lagerstedt","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden"},{"name":"Islet Cell Exocytosis, Lund University Diabetes Centre, Department of Clinical Sciences Malm\u00f6, Lund University, 20506 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration (2009). Major Lipids, Apolipoproteins, and Risk of Vascular Disease. JAMA, 302, 1993.","DOI":"10.1001\/jama.2009.1619"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2003.11.024","article-title":"Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice","volume":"327","author":"Pastore","year":"2004","journal-title":"Gene"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/db15-1493","article-title":"Dual actions of apolipoprotein A-I on glucose-stimulated insulin secretion and insulin-independent peripheral tissue glucose uptake lead to increased heart and skeletal muscle glucose disposal","volume":"65","author":"Lindahl","year":"2016","journal-title":"Diabetes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165613","DOI":"10.1016\/j.bbadis.2019.165613","article-title":"Apolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretion","volume":"1866","author":"Nilsson","year":"2020","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2353\/jmoldx.2009.080161","article-title":"Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: Identification of three novel mutations in the APOA1 gene","volume":"11","author":"Eriksson","year":"2009","journal-title":"J. Mol. Diagn."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13506129.2015.1077217","article-title":"Amyloid cardiomyopathy associated with a novel apolipoprotein A-I Q172P variant","volume":"22","author":"Vonberg","year":"2015","journal-title":"Amyloid"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2011.06.024","article-title":"Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I","volume":"179","author":"Rowczenio","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nep.13278","article-title":"Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis","volume":"23","author":"Horike","year":"2018","journal-title":"Nephrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/acs.biochem.8b00817","article-title":"Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation","volume":"57","author":"Morgado","year":"2018","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/febs.12809","article-title":"Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing\u2014A common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis","volume":"281","author":"Das","year":"2014","journal-title":"FEBS J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.bbadis.2017.09.001","article-title":"Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels","volume":"1863","author":"Iacobucci","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/bi2017014","article-title":"The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment","volume":"51","author":"Gursky","year":"2012","journal-title":"Biochemistry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/j.1600-6143.2006.01507.x","article-title":"Organ transplantation in hereditary apolipoprotein AI amyloidosis","volume":"6","author":"Gillmore","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_16","first-page":"jlr.RA120000920","article-title":"Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux","volume":"62","author":"Nilsson","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506120600960288","article-title":"Structure, function and amyloidogenic propensity of apolipoprotein A-I","volume":"13","author":"Obici","year":"2006","journal-title":"Amyloid"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1053\/j.gastro.2004.03.003","article-title":"Liver Biopsy Discloses a New Apolipoprotein A-I Hereditary Amyloidosis in Several Unrelated Italian Families","volume":"126","author":"Obici","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0888-7543(90)90288-6","article-title":"A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy","volume":"8","author":"Nichols","year":"1990","journal-title":"Genomics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1110\/ps.29201","article-title":"Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure","volume":"10","author":"Mangione","year":"2001","journal-title":"Protein Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0002-9440(10)65064-X","article-title":"Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis","volume":"156","author":"Vital","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15252\/emmm.201404190","article-title":"Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity","volume":"6","author":"Guan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30391","DOI":"10.1038\/srep30391","article-title":"Iowa Mutant Apolipoprotein A-I (ApoA-I Iowa) Fibrils Target Lysosomes","volume":"6","author":"Kameyama","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/j.1582-4934.2011.01271.x","article-title":"Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells","volume":"15","author":"Arciello","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_25","first-page":"601","article-title":"Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie","volume":"63","author":"Snow","year":"1990","journal-title":"Lab. Investig."},{"key":"ref_26","first-page":"951","article-title":"Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus","volume":"116","author":"Young","year":"1992","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fj.05-4682rev","article-title":"Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation","volume":"20","author":"Taylor","year":"2006","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13822","DOI":"10.1021\/acs.analchem.0c02390","article-title":"Raman Spectroscopy with 2D Perturbation Correlation Moving Windows for the Characterization of Heparin-Amyloid Interactions","volume":"92","author":"Townsend","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/acs.biochem.6b01120","article-title":"Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising \u03b1-Helical and \u03b2-Sheet Structures","volume":"56","author":"Townsend","year":"2017","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/anie.200904781","article-title":"Nanoscale flexibility parameters of Alzheimer amyloid fibrils determined by electron cryo-microscopy","volume":"49","author":"Sachse","year":"2010","journal-title":"Angew. Chem.-Int. Ed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Cardoso","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-291X(02)00465-5","article-title":"Only amyloidogenic intermediates of transthyretin induce apoptosis","volume":"294","author":"Andersson","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24210","DOI":"10.1074\/jbc.M115.652545","article-title":"Cellular interaction and cytotoxicity of the Iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate","volume":"290","author":"Kuwabara","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1038\/cddis.2014.45","article-title":"Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin","volume":"5","author":"Monti","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"Jayaraman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Del Giudice, R., Imbimbo, P., Pietrocola, F., Martins, I., De Palma, F.D.E., Bravo-San Pedro, J.M., Kroemer, G., Maiuri, M.C., and Monti, D.M. (2022). Autophagy Alteration in ApoA-I Related Systemic Amyloidosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073498"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbagen.2017.11.018","article-title":"Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: Predestination or serendipity?","volume":"1862","author":"Gaglione","year":"2018","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13506120500535768","article-title":"Glycosaminoglycans are part of amyloid fibrils: Ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold","volume":"13","author":"Gruys","year":"2006","journal-title":"Amyloid"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and \u03b2-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"Wandosell","year":"2002","journal-title":"Peptides"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbrc.2016.04.092","article-title":"Heparin interactions with apoA1 and SAA in inflammation-associated HDL","volume":"474","author":"Digre","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1194\/jlr.M020883","article-title":"The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils","volume":"53","author":"Petrlova","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pro.3522","article-title":"High-efficient bacterial production of human ApoA-I amyloidogenic variants","volume":"27","author":"Lagerstedt","year":"2018","journal-title":"Protein Sci."},{"key":"ref_44","first-page":"1","article-title":"Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants","volume":"7","author":"Nilsson","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.4049\/jimmunol.1302305","article-title":"The Epidermal Growth Factor Receptor Is a Regulator of Epidermal Complement Component Expression and Complement Activation","volume":"192","author":"Ananthoju","year":"2014","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1107\/S0909049511038982","article-title":"Circular dichroism beamline B23 at the Diamond Light Source","volume":"19","author":"Hussain","year":"2012","journal-title":"J. Synchrotron Radiat."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Siligardi, G., and Hussain, R. (2014). CD Spectroscopy: An essential tool for quality control of protein folding. Structural Proteomics: High-Throughput Methods, Humana Press. [2nd ed.].","DOI":"10.1007\/978-1-4939-2230-7_14"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1107\/S1600577514028161","article-title":"CDApps : Integrated software for experimental planning and data processing at beamline B23, Diamond Light Source","volume":"22","author":"Hussain","year":"2015","journal-title":"J. Synchrotron Radiat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/bi00504a006","article-title":"Estimation of Globular Protein Secondary Structure from Circular Dichroism","volume":"20","author":"Provencher","year":"1981","journal-title":"Biochemistry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"16413","DOI":"10.1021\/bi051018v","article-title":"F\u00f6rster resonance energy transfer measurements are consistent with a helical bundle model for lipid-free apolipoprotein A-I","volume":"44","author":"Brouillette","year":"2005","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"38028","DOI":"10.1038\/srep38028","article-title":"High-throughput SRCD using multi-well plates and its applications","volume":"6","author":"Hussain","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/318\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:50:26Z","timestamp":1760147426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010318"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010318","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]}}}